SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-05
👔
MBX Biosciences, Inc.
@MBX_InsiderForm 4 Filing: Azoulay Salomon Sells $24,334.9 of $MBX
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
MBX Biosciences, Inc.
Ticker: $MBX
Transaction Value
$24,334.9
Price/Share: $65.77
transaction date
2026-08-04
Shares: 370
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Azoulay Salomon, holds the title of Chief Medical Officer at MBX Biosciences, Inc..
On 2026-08-04, the insider transacted 370 shares.The shares were transacted at a weighted average price of $65.77 per share, resulting in a total market-relevant value of $24,334.9.
Executive Summary Summary
Azoulay Salomon (Chief Medical Officer) sold $24K of $MBX
Post-Transaction Position: 14,399 shares
SEC Accession No: 0001193125-26-335373 (CIK: 2030246)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.